These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 33427520)

  • 21. Injectable deferoxamine nanoparticles loaded chitosan-hyaluronic acid coacervate hydrogel for therapeutic angiogenesis.
    S V; A S; Annapoorna M; R J; Subramania I; Shantikumar V N; R J
    Colloids Surf B Biointerfaces; 2018 Jan; 161():129-138. PubMed ID: 29055865
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combination therapy targeting integrins reduces glioblastoma tumor growth through antiangiogenic and direct antitumor activity and leads to activation of the pro-proliferative prolactin pathway.
    Oliveira-Ferrer L; Wellbrock J; Bartsch U; Penas EM; Hauschild J; Klokow M; Bokemeyer C; Fiedler W; Schuch G
    Mol Cancer; 2013 Nov; 12(1):144. PubMed ID: 24257371
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synergic effect of PD-1 blockade and endostar on the PI3K/AKT/mTOR-mediated autophagy and angiogenesis in Lewis lung carcinoma mouse model.
    Wu J; Zhao X; Sun Q; Jiang Y; Zhang W; Luo J; Li Y
    Biomed Pharmacother; 2020 May; 125():109746. PubMed ID: 32106386
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potent inhibition of Lewis lung cancer growth by heyneanol A from the roots of Vitis amurensis through apoptotic and anti-angiogenic activities.
    Lee EO; Lee HJ; Hwang HS; Ahn KS; Chae C; Kang KS; Lu J; Kim SH
    Carcinogenesis; 2006 Oct; 27(10):2059-69. PubMed ID: 16675471
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Continuous administration of endostatin by intraperitoneally implanted osmotic pump improves the efficacy and potency of therapy in a mouse xenograft tumor model.
    Kisker O; Becker CM; Prox D; Fannon M; D'Amato R; Flynn E; Fogler WE; Sim BK; Allred EN; Pirie-Shepherd SR; Folkman J
    Cancer Res; 2001 Oct; 61(20):7669-74. PubMed ID: 11606410
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Conjugation of gold nanoparticles and recombinant human endostatin modulates vascular normalization via interruption of anterior gradient 2-mediated angiogenesis.
    Pan F; Yang W; Li W; Yang XY; Liu S; Li X; Zhao X; Ding H; Qin L; Pan Y
    Tumour Biol; 2017 Jul; 39(7):1010428317708547. PubMed ID: 28714365
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recombinant human endostatin combined with radiotherapy inhibits colorectal cancer growth.
    Zhang K; Wang Y; Yu X; Shi Y; Yao Y; Wei X; Ma X
    BMC Cancer; 2017 Dec; 17(1):899. PubMed ID: 29282026
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optimization of hyaluronic acid-tyramine/silk-fibroin composite hydrogels for cartilage tissue engineering and delivery of anti-inflammatory and anabolic drugs.
    Ziadlou R; Rotman S; Teuschl A; Salzer E; Barbero A; Martin I; Alini M; Eglin D; Grad S
    Mater Sci Eng C Mater Biol Appl; 2021 Jan; 120():111701. PubMed ID: 33545860
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immune response against 3LL Lewis lung carcinoma potentiates the therapeutic efficacy of endostatin.
    Li M; Huang X; Zhu Z; Wong M; Watkins S; Zhao Q; Herberman R; Gorelik E
    J Immunother; 2001; 24(6):472-81. PubMed ID: 11759070
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Barbigerone, an isoflavone, inhibits tumor angiogenesis and human non-small-cell lung cancer xenografts growth through VEGFR2 signaling pathways.
    Li X; Wang X; Ye H; Peng A; Chen L
    Cancer Chemother Pharmacol; 2012 Sep; 70(3):425-37. PubMed ID: 22814678
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Down-regulation of vascular endothelial growth factor and up-regulation of pigment epithelium derived factor make low molecular weight heparin-endostatin and polyethylene glycol-endostatin potential candidates for anti-angiogenesis drug.
    Tan H; Mu G; Zhu W; Liu J; Wang F
    Biol Pharm Bull; 2011; 34(4):545-50. PubMed ID: 21467643
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Simulation of tumor-induced angiogenesis and its response to anti-angiogenic drug treatment: mode of drug delivery and clearance rate dependencies.
    Tee D; DiStefano J
    J Cancer Res Clin Oncol; 2004 Jan; 130(1):15-24. PubMed ID: 14586644
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibitory effects of icotinib combined with antiangiogenic drugs in human non-small cell lung cancer xenograft models are better than single target drugs.
    Jiang P; Zhang Y; Cui J; Wang X; Li Y
    Thorac Cancer; 2022 Jan; 13(2):257-264. PubMed ID: 34855286
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of the effects of recombinant human endostatin and docetaxel on human umbilical vein endothelial cells in different growth states.
    Xu WJ; Huang C; Wang J; Jiang RC; Wang LC; Lin L; Liu ZJ; Sun BC; Li K
    Chin Med J (Engl); 2011 Sep; 124(18):2883-9. PubMed ID: 22040497
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Resveratrol isolated from Polygonum cuspidatum root prevents tumor growth and metastasis to lung and tumor-induced neovascularization in Lewis lung carcinoma-bearing mice.
    Kimura Y; Okuda H
    J Nutr; 2001 Jun; 131(6):1844-9. PubMed ID: 11385077
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of lysine acetyltransferases impairs tumor angiogenesis acting on both endothelial and tumor cells.
    Di Martile M; Gabellini C; Desideri M; Matraxia M; Farini V; Valentini E; Carradori S; Ercolani C; Buglioni S; Secci D; Andreazzoli M; Del Bufalo D; Trisciuoglio D
    J Exp Clin Cancer Res; 2020 Jun; 39(1):103. PubMed ID: 32498717
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 6-(1-Oxobutyl)-5,8-dimethoxy-1,4-naphthoquinone inhibits lewis lung cancer by antiangiogenesis and apoptosis.
    Lee HJ; Lee HJ; Song GY; Li G; Lee JH; Lü J; Kim SH
    Int J Cancer; 2007 Jun; 120(11):2481-90. PubMed ID: 17311288
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An injectable hyaluronic acid-tyramine hydrogel system for protein delivery.
    Lee F; Chung JE; Kurisawa M
    J Control Release; 2009 Mar; 134(3):186-93. PubMed ID: 19121348
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular and functional evaluation of a novel HIF inhibitor, benzopyranyl 1,2,3-triazole compound.
    Park K; Lee HE; Lee SH; Lee D; Lee T; Lee YM
    Oncotarget; 2017 Jan; 8(5):7801-7813. PubMed ID: 27999195
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Norcantharidin: a potential antiangiogenic agent for gallbladder cancers in vitro and in vivo.
    Zhang JT; Fan YZ; Chen CQ; Zhao ZM; Sun W
    Int J Oncol; 2012 May; 40(5):1501-14. PubMed ID: 22200632
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.